Kaleido Biosciences fundamentals help investors to digest information that contributes to Kaleido Biosciences' financial success or failures. It also enables traders to predict the movement of Kaleido Stock. This fundamental analysis module provides a way for investors to measures Kaleido Biosciences' intrinsic value by examining all of its available economic and financial indicators and drivers, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Kaleido Biosciences stock. Please note, this module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.
Search Fundamentals
Kaleido
Select Account or Indicator
Earnings Before Interest Taxes and Depreciation Amortization EBITDA
Earnings Before Interest Taxes and Depreciation Amortization USD
Earnings before Tax
Free Cash Flow
Invested Capital
Tangible Asset Value
Working Capital
Book Value per Share
Current Ratio
Debt to Equity Ratio
Earnings per Basic Share
Earnings per Diluted Share
Earnings per Basic Share USD
Free Cash Flow per Share
Tangible Assets Book Value per Share
Capital Expenditure
Depreciation Amortization and Accretion
Net Cash Flow or Change in Cash and Cash Equivalents
Kaleido Biosciences' Z-Score is a simple linear, multi-factor model that measures the financial health and economic stability of a company. The score is used to predict the probability of a firm going into bankruptcy within next 24 months or two fiscal years from the day stated on the accounting statements used to calculate it. The model uses five fundamental business ratios that are weighted according to algorithm of Professor Edward Altman who developed it in the late 1960s at New York University..
Most of Kaleido Biosciences' fundamental indicators, such as Z Score, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Kaleido Biosciences is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
First Factor
=
1.2 * (
Working Capital
/
Total Assets )
Second Factor
=
1.4 * (
Retained Earnings
/
Total Assets )
Thrid Factor
=
3.3 * (
EBITAD
/
Total Assets )
Fouth Factor
=
0.6 * (
Market Value of Equity
/
Total Liabilities )
Fifth Factor
=
0.99 * (
Revenue
/
Total Assets )
To calculate Z-Score one would need to know current working capital of the company, its total assets, and liabilities, amount of latest retained earnings as well as earnings before interest and tax. Z-Score can be used to compare the odds of bankruptcy of companies in a similar line of business or firms operating in the same industry. Companies with Z-Scores above 3.1 are generally considered to be stable and healthy with a low probability of bankruptcy. Scores that fall between 1.8 and 3.1 lie in a so-called 'grey area' with scores of less than 1, indicating the high probability of distress. Z Score is used widely by financial auditors, accountants, money managers, loan processers, wealth advisers, as well as day traders. In the last 25 years, many financial models that utilize z score has been proved to be successful as a predictor of corporate bankruptcy.
Based on the company's disclosures, Kaleido Biosciences has a Z Score of 3.8. This is 43.7% lower than that of the Healthcare sector and 13.77% higher than that of the Biotechnology industry. The z score for all United States stocks is 56.42% higher than that of the company.
Kaleido Biosciences Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Kaleido Biosciences's current stock value. Our valuation model uses many indicators to compare Kaleido Biosciences value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Kaleido Biosciences competition to find correlations between indicators driving Kaleido Biosciences's intrinsic value. More Info.
Kaleido Biosciences is currently regarded as number one stock in z score category among related companies. It is currently regarded as number one stock in working capital category among related companies reporting about 16,458,961 of Working Capital per Z Score. . Kaleido Biosciences Working Capital is quite stable at the moment as compared to the past year. The company's current value of Working Capital is estimated at 43.59 Million
Kaleido Biosciences is currently regarded as number one stock in market capitalization category among related companies. Market capitalization of Biotechnology industry is now estimated at about 1.83 Billion. Kaleido Biosciences retains roughly 235.13 Million in market capitalization claiming about 13% of stocks in Biotechnology industry.
The Macroaxis Fundamental Analysis modules help investors analyze Kaleido Biosciences's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Kaleido Biosciences using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Kaleido Biosciences based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Kaleido Biosciences, Inc., a clinical-stage healthcare company, develops microbiome metabolic therapies. The company was incorporated in 2015 and is headquartered in Lexington, Massachusetts. Kaleido Biosciences operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 82 people.
Kaleido Biosciences Investors Sentiment
The influence of Kaleido Biosciences' investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Kaleido. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock markets does not have a solid backing from leading economists and market statisticians.
Current Sentiment - KLDO
Kaleido Biosciences Investor Sentiment
Macroaxis portfolio users are evenly split in their trading attitude regarding investing in Kaleido Biosciences. What is your trading attitude regarding investing in Kaleido Biosciences? Are you bullish or bearish?
Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as Kaleido Biosciences using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.
Build Optimal Portfolios
Align your risk with return expectations
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations
Please see Kaleido Biosciences Piotroski F Score and Kaleido Biosciences Altman Z Score analysis. Note that the Kaleido Biosciences information on this page should be used as a complementary analysis to other Kaleido Biosciences' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.
Complementary Tools for Kaleido Stock analysis
When running Kaleido Biosciences price analysis, check to measure Kaleido Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Kaleido Biosciences is operating at the current time. Most of Kaleido Biosciences' value examination focuses on studying past and present price action to predict the probability of Kaleido Biosciences' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Kaleido Biosciences' price. Additionally, you may evaluate how the addition of Kaleido Biosciences to your portfolios can decrease your overall portfolio volatility.
Volatility AnalysisGet historical volatility and risk analysis based on latest market data
Theme RatingsDetermine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
The market value of Kaleido Biosciences is measured differently than its book value, which is the value of Kaleido that is recorded on the company's balance sheet. Investors also form their own opinion of Kaleido Biosciences' value that differs from its market value or its book value, called intrinsic value, which is Kaleido Biosciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Kaleido Biosciences' market value can be influenced by many factors that don't directly affect Kaleido Biosciences underlying business (such as pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Kaleido Biosciences' value and its price as these two are different measures arrived at by different means. Investors typically determine Kaleido Biosciences value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Kaleido Biosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.